Roche says its investigational breast cancer pill could outsell Herceptinnews2026-04-23T10:47:53+00:00April 23rd, 2026|Endpoints News|
Sanofi defends Garijo appointment, says it is ‘fully committed’ to immunologynews2026-04-23T09:00:47+00:00April 23rd, 2026|Endpoints News|
AbbVie’s North Carolina $1.4B manufacturing site to finish during Trump’s termnews2026-04-22T18:38:54+00:00April 22nd, 2026|Endpoints News|
Sanofi’s new CEO faces a reckoning on immunology-focused R&D strategynews2026-04-22T15:25:28+00:00April 22nd, 2026|Endpoints News|
Rigel loses Lilly alliance in pharma industry’s latest RIPK exitnews2026-04-22T14:41:53+00:00April 22nd, 2026|Endpoints News|
Medicare indefinitely delays pilot plan to cover weight loss drugsnews2026-04-21T20:21:55+00:00April 21st, 2026|Endpoints News|
FDA approves once-daily HIV pill from Mercknews2026-04-21T17:01:03+00:00April 21st, 2026|Endpoints News|
Soleno sold at a discount to Neurocrine due to dwindling European prospectsnews2026-04-21T10:33:59+00:00April 21st, 2026|Endpoints News|
Trump, FDA plan to expedite psychedelic developmentnews2026-04-20T19:04:11+00:00April 20th, 2026|Endpoints News|
Novartis cuts two programs in cancer-related blood clotsnews2026-04-20T18:24:47+00:00April 20th, 2026|Endpoints News|
